Jeffrey Aronin is the founder of Emalex Biosciences. Emalex Biosciences has raised $285M in total funding. Latest round: Series D.
Jeffrey Aronin is the founder and CEO of Emalex Biosciences, a biopharmaceutical company focused on developing therapies for Tourette syndrome. He previously founded and served as CEO of Paragon Biosciences, which played a key role in Emalex's funding.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide